Researcher.Life Logo

American Journal of Cardiovascular Drugs : Impact Factor & More

eISSN: 1179-187XpISSN: 1175-3277

Key Metrics

CiteScore
5.9
Eigenfactor
0.001 - 0.005
H-Index
57
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on American Journal of Cardiovascular Drugs

American Journal of Cardiovascular Drugs Journal Specifications

Overview
Publisher ADIS INT LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in American Journal of Cardiovascular Drugs ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in American Journal of Cardiovascular Drugs

Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".
  • 18 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Comment on: "Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide".
  • 18 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.
  • 16 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
  • 9 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
  • 30 Apr 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
  • 29 Apr 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Author's Reply to: "Comment on: Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials Including 31,397 Subjects Worldwide".
  • 18 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Comment on: "Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide".
  • 18 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.
  • 16 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Efficacy and Safety of Ongericimab in Chinese Patients with Hypercholesterolemia: A Meta-analysis of Randomized Controlled Trials.
  • 9 May 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
Rapid Access Atrial Fibrillation Clinics in Australia - Modelling Outcomes and Cost-Effectiveness.
  • 30 Apr 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions
A Comprehensive, Updated Review of Ezetimibe: Evidence-Based Clinical Use for Atherosclerotic Cardiovascular Disease.
  • 29 Apr 2026
  • American journal of cardiovascular drugs : drugs, devices, and other interventions

FAQs on American Journal of Cardiovascular Drugs